作者: Jinghong Dai , Yali Xiong , Hui Li , Yajun Qian , Ying Xu
DOI: 10.1007/S10067-020-05172-7
关键词:
摘要: Coronavirus disease 2019 (COVID-19) pneumonia, firstly reported in Wuhan, Hubei province, China, has rapidly spread around the world with high mortality rate among critically ill patients. The use of corticosteroids COVID-19 remains a major controversy. Available evidences are inconclusive. According to WHO guidance, not recommended be used unless for another reason. Chinese Thoracic Society (CTS) proposes an expert consensus statement that suggests taking prudent attitude corticosteroid usage. In our clinical practice, we do routinely; only low-to-moderate doses were given several severely patients prudently. this paper, will present two confirmed severe cases admitted isolation wards Optical Valley Campus Tongji hospital, Medical College, Huazhong University Science and Technology. We discuss questions related usages.